Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prophylactic Intrathecal Thiotepa Plus Stupp Regimen for Glioblastoma (PRISM)
NCT07511725Phase 2Recruiting
- Sponsor
- Second Affiliated Hospital of Zhejiang University School of Medicine
- Start
- Jan 2026
- Primary completion
- Jan 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of thiotepa in glioblastoma (GBM), sponsored by Second Affiliated Hospital of Zhejiang University School of Medicine. Started Jan 2026; status: recruiting.
02
Drugs
thiotepa
03
Conditions
glioblastoma (GBM)
Beyond the preview
Go deeper on NCT07511725.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07511725.